Predictors of early mortality in veteran patients with pancreatic cancer

Ali Siddiqui, John Heinzerling, Edward H. Livingston, Sergio Huerta

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Background: Identification of predictors of outcome may assist in guiding treatment options for patients with pancreatic cancer. The aim of the current study was to determine clinical factors and laboratory values that predicted mortality of less than 6 months in a male population of the same age and body mass index at the time of diagnosis of pancreatic cancer who died as a result of their disease. Methods: Only patients with proven diagnosis of pancreatic cancer (n = 69) were included in the study. Patients were grouped into early (≤6 months; n = 31) and late (>6 months; n = 38) survivors. Forty-four clinical factors were assessed by univariate analysis. Significant factors (P <.05) were included in a multivariate regression model to determine independent predictors of early mortality. Results: All patients in the cohort were men. Both the early and late death cohorts were of similar age and body mass index. Twenty-five patients (36%) underwent surgical intervention (palliative 17%, exploratory laparotomy without resection 6%, pancreaticoduodenectomy 13%). Thirty-six patients (52%) underwent placement of a biliary stent. Eight patients received exclusively palliative care. The mean overall length of survival was 7.8 ± .6 months. Univariate analysis demonstrated that patients who died within 6 months had a significantly increased blood level of carbohydrate antigen 19-9, alkaline phosphatase, and white blood cell (WBC) count. Early mortalities also had a decreased blood albumin level. Multivariate analysis of these factors revealed that low serum albumin and an increased WBC count independently predicted survival of less than 6 months. Conclusion: Serum albumin and WBC count may be used in conjunction with other diagnostic modalities and overall patient status in determining treatment options for patients with pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)362-366
Number of pages5
JournalAmerican Journal of Surgery
Volume194
Issue number3
DOIs
StatePublished - Sep 2007

Fingerprint

Veterans
Pancreatic Neoplasms
Mortality
Leukocyte Count
Serum Albumin
Body Mass Index
Pancreaticoduodenectomy
Survival
Palliative Care
Laparotomy
Stents
Alkaline Phosphatase
Survivors
Albumins
Multivariate Analysis
Carbohydrates
Antigens

Keywords

  • Multivariate analysis
  • Pancreatic neoplasms
  • Prognosis
  • Univariate analysis

ASJC Scopus subject areas

  • Surgery

Cite this

Predictors of early mortality in veteran patients with pancreatic cancer. / Siddiqui, Ali; Heinzerling, John; Livingston, Edward H.; Huerta, Sergio.

In: American Journal of Surgery, Vol. 194, No. 3, 09.2007, p. 362-366.

Research output: Contribution to journalArticle

Siddiqui, Ali ; Heinzerling, John ; Livingston, Edward H. ; Huerta, Sergio. / Predictors of early mortality in veteran patients with pancreatic cancer. In: American Journal of Surgery. 2007 ; Vol. 194, No. 3. pp. 362-366.
@article{7cffec09884d4596ae5dc27082d301cd,
title = "Predictors of early mortality in veteran patients with pancreatic cancer",
abstract = "Background: Identification of predictors of outcome may assist in guiding treatment options for patients with pancreatic cancer. The aim of the current study was to determine clinical factors and laboratory values that predicted mortality of less than 6 months in a male population of the same age and body mass index at the time of diagnosis of pancreatic cancer who died as a result of their disease. Methods: Only patients with proven diagnosis of pancreatic cancer (n = 69) were included in the study. Patients were grouped into early (≤6 months; n = 31) and late (>6 months; n = 38) survivors. Forty-four clinical factors were assessed by univariate analysis. Significant factors (P <.05) were included in a multivariate regression model to determine independent predictors of early mortality. Results: All patients in the cohort were men. Both the early and late death cohorts were of similar age and body mass index. Twenty-five patients (36{\%}) underwent surgical intervention (palliative 17{\%}, exploratory laparotomy without resection 6{\%}, pancreaticoduodenectomy 13{\%}). Thirty-six patients (52{\%}) underwent placement of a biliary stent. Eight patients received exclusively palliative care. The mean overall length of survival was 7.8 ± .6 months. Univariate analysis demonstrated that patients who died within 6 months had a significantly increased blood level of carbohydrate antigen 19-9, alkaline phosphatase, and white blood cell (WBC) count. Early mortalities also had a decreased blood albumin level. Multivariate analysis of these factors revealed that low serum albumin and an increased WBC count independently predicted survival of less than 6 months. Conclusion: Serum albumin and WBC count may be used in conjunction with other diagnostic modalities and overall patient status in determining treatment options for patients with pancreatic cancer.",
keywords = "Multivariate analysis, Pancreatic neoplasms, Prognosis, Univariate analysis",
author = "Ali Siddiqui and John Heinzerling and Livingston, {Edward H.} and Sergio Huerta",
year = "2007",
month = "9",
doi = "10.1016/j.amjsurg.2007.02.007",
language = "English (US)",
volume = "194",
pages = "362--366",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Predictors of early mortality in veteran patients with pancreatic cancer

AU - Siddiqui, Ali

AU - Heinzerling, John

AU - Livingston, Edward H.

AU - Huerta, Sergio

PY - 2007/9

Y1 - 2007/9

N2 - Background: Identification of predictors of outcome may assist in guiding treatment options for patients with pancreatic cancer. The aim of the current study was to determine clinical factors and laboratory values that predicted mortality of less than 6 months in a male population of the same age and body mass index at the time of diagnosis of pancreatic cancer who died as a result of their disease. Methods: Only patients with proven diagnosis of pancreatic cancer (n = 69) were included in the study. Patients were grouped into early (≤6 months; n = 31) and late (>6 months; n = 38) survivors. Forty-four clinical factors were assessed by univariate analysis. Significant factors (P <.05) were included in a multivariate regression model to determine independent predictors of early mortality. Results: All patients in the cohort were men. Both the early and late death cohorts were of similar age and body mass index. Twenty-five patients (36%) underwent surgical intervention (palliative 17%, exploratory laparotomy without resection 6%, pancreaticoduodenectomy 13%). Thirty-six patients (52%) underwent placement of a biliary stent. Eight patients received exclusively palliative care. The mean overall length of survival was 7.8 ± .6 months. Univariate analysis demonstrated that patients who died within 6 months had a significantly increased blood level of carbohydrate antigen 19-9, alkaline phosphatase, and white blood cell (WBC) count. Early mortalities also had a decreased blood albumin level. Multivariate analysis of these factors revealed that low serum albumin and an increased WBC count independently predicted survival of less than 6 months. Conclusion: Serum albumin and WBC count may be used in conjunction with other diagnostic modalities and overall patient status in determining treatment options for patients with pancreatic cancer.

AB - Background: Identification of predictors of outcome may assist in guiding treatment options for patients with pancreatic cancer. The aim of the current study was to determine clinical factors and laboratory values that predicted mortality of less than 6 months in a male population of the same age and body mass index at the time of diagnosis of pancreatic cancer who died as a result of their disease. Methods: Only patients with proven diagnosis of pancreatic cancer (n = 69) were included in the study. Patients were grouped into early (≤6 months; n = 31) and late (>6 months; n = 38) survivors. Forty-four clinical factors were assessed by univariate analysis. Significant factors (P <.05) were included in a multivariate regression model to determine independent predictors of early mortality. Results: All patients in the cohort were men. Both the early and late death cohorts were of similar age and body mass index. Twenty-five patients (36%) underwent surgical intervention (palliative 17%, exploratory laparotomy without resection 6%, pancreaticoduodenectomy 13%). Thirty-six patients (52%) underwent placement of a biliary stent. Eight patients received exclusively palliative care. The mean overall length of survival was 7.8 ± .6 months. Univariate analysis demonstrated that patients who died within 6 months had a significantly increased blood level of carbohydrate antigen 19-9, alkaline phosphatase, and white blood cell (WBC) count. Early mortalities also had a decreased blood albumin level. Multivariate analysis of these factors revealed that low serum albumin and an increased WBC count independently predicted survival of less than 6 months. Conclusion: Serum albumin and WBC count may be used in conjunction with other diagnostic modalities and overall patient status in determining treatment options for patients with pancreatic cancer.

KW - Multivariate analysis

KW - Pancreatic neoplasms

KW - Prognosis

KW - Univariate analysis

UR - http://www.scopus.com/inward/record.url?scp=34547681625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547681625&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2007.02.007

DO - 10.1016/j.amjsurg.2007.02.007

M3 - Article

C2 - 17693283

AN - SCOPUS:34547681625

VL - 194

SP - 362

EP - 366

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 3

ER -